AccueilGroupesDiscussionsPlusTendances
Site de recherche
Ce site utilise des cookies pour fournir nos services, optimiser les performances, pour les analyses, et (si vous n'êtes pas connecté) pour les publicités. En utilisant Librarything, vous reconnaissez avoir lu et compris nos conditions générales d'utilisation et de services. Votre utilisation du site et de ses services vaut acceptation de ces conditions et termes.

Résultats trouvés sur Google Books

Cliquer sur une vignette pour aller sur Google Books.

Bad Blood: Secrets and Lies in a Silicon…
Chargement...

Bad Blood: Secrets and Lies in a Silicon Valley Startup (original 2018; édition 2018)

par John Carreyrou (Auteur)

MembresCritiquesPopularitéÉvaluation moyenneMentions
2,6871855,390 (4.31)97
"The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--… (plus d'informations)
Membre:BioTerp
Titre:Bad Blood: Secrets and Lies in a Silicon Valley Startup
Auteurs:John Carreyrou (Auteur)
Info:Knopf (2018), Edition: 1, 352 pages
Collections:Lus mais non possédés, Library
Évaluation:
Mots-clés:Read, Non Fiction

Information sur l'oeuvre

Bad Blood: Secrets and Lies in a Silicon Valley Startup par John Carreyrou (2018)

Chargement...

Inscrivez-vous à LibraryThing pour découvrir si vous aimerez ce livre

Actuellement, il n'y a pas de discussions au sujet de ce livre.

» Voir aussi les 97 mentions

Anglais (183)  Suédois (1)  Toutes les langues (184)
Affichage de 1-5 de 184 (suivant | tout afficher)
Surprisingly readable investigative story. I was worried that there would be too many characters to keep track of, but each chapter concentrates on a certain group that then disappears from focus (often because they get fired).
( )
  Levitara | Apr 5, 2024 |
This is an incredible expose about Elizabeth Holmes, 20 years old, college drop out before sophomore year, charismatic and with a desire for "a purposeful life". She patented her idea to develop an in-home mini lab where individuals can administer their own blood test with a single drop of blood and transfer the info to their doctor for treatment recommendations, if necessary.
In the span of 10 years Theranos, the start-up which Holmes created, went from a little blood testing machine to, well, a little non-functioning blood testing machine. Through quick thinking, being evasive and using outside testing facilities for accurate results was she was able to receive the backing of the US Army and former Secretaries of State, George Schultz and Henry Kissinger.
How does this flimsy start-up come to an end? A phone call to a Wall Street Journal journalist named John Carryrou from a suspicious employee. ( )
  Carmenere | Apr 2, 2024 |
Highly informative and interesting. Could barely put it down. Simply fantastic. ( )
  guildlingsfan | Mar 28, 2024 |
The thing about this being a page-turner was no joke: i read it in three days. ( )
  aleshh | Jan 12, 2024 |
This one totally led up to the hype. This level selling people on complete BS totally happens and it takes you back all the times you've been in a meeting and thought "yeah right" this is that out of control. Written like a true investigative report it gives the facts objectively but not so dry it's boring. Very well written, the ordering made sense and wasn't confusing or hard to follow even when listening as an audiobook, a hard feat for this type of book. ( )
  hellokirsti | Jan 3, 2024 |
Affichage de 1-5 de 184 (suivant | tout afficher)
The author’s description of Holmes as a manic leader who turned coolly hostile when challenged is ripe material for a psychologist; Carreyrou wisely lets the evidence speak for itself. As presented here, Holmes harbored delusions of grandeur but couldn’t cope with the messy realities of bioengineering. Swathed in her own reality distortion field, she dressed in black turtlenecks to emulate her idol Jobs and preached that the Theranos device was “the most important thing humanity has ever built.” Employees were discouraged from questioning this cultish orthodoxy by her “ruthlessness” and her “culture of fear.” Secrecy was obsessive. Labs and doors were equipped with fingerprint scanners.
 

» Ajouter d'autres auteur(e)s

Nom de l'auteurRôleType d'auteurŒuvre ?Statut
John Carreyrouauteur principaltoutes les éditionscalculé
Damron, WillNarrateurauteur secondairequelques éditionsconfirmé
Vous devez vous identifier pour modifier le Partage des connaissances.
Pour plus d'aide, voir la page Aide sur le Partage des connaissances [en anglais].
Titre canonique
Titre original
Titres alternatifs
Date de première publication
Personnes ou personnages
Informations provenant du Partage des connaissances anglais. Modifiez pour passer à votre langue.
Lieux importants
Informations provenant du Partage des connaissances anglais. Modifiez pour passer à votre langue.
Évènements importants
Informations provenant du Partage des connaissances anglais. Modifiez pour passer à votre langue.
Films connexes
Informations provenant du Partage des connaissances anglais. Modifiez pour passer à votre langue.
Épigraphe
Dédicace
Informations provenant du Partage des connaissances anglais. Modifiez pour passer à votre langue.
For Molly, Sebastian, Jack, and Francesca
Premiers mots
Informations provenant du Partage des connaissances anglais. Modifiez pour passer à votre langue.
Tim Kemp had good news for his team.
Citations
Derniers mots
Informations provenant du Partage des connaissances anglais. Modifiez pour passer à votre langue.
(Cliquez pour voir. Attention : peut vendre la mèche.)
Notice de désambigüisation
Directeur de publication
Courtes éloges de critiques
Informations provenant du Partage des connaissances anglais. Modifiez pour passer à votre langue.
Langue d'origine
Informations provenant du Partage des connaissances anglais. Modifiez pour passer à votre langue.
DDC/MDS canonique
LCC canonique

Références à cette œuvre sur des ressources externes.

Wikipédia en anglais

Aucun

"The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--

Aucune description trouvée dans une bibliothèque

Description du livre
Résumé sous forme de haïku

Discussion en cours

Aucun

Couvertures populaires

Vos raccourcis

Évaluation

Moyenne: (4.31)
0.5
1 10
1.5
2 7
2.5 1
3 81
3.5 33
4 331
4.5 70
5 397

Est-ce vous ?

Devenez un(e) auteur LibraryThing.

 

À propos | Contact | LibraryThing.com | Respect de la vie privée et règles d'utilisation | Aide/FAQ | Blog | Boutique | APIs | TinyCat | Bibliothèques historiques | Critiques en avant-première | Partage des connaissances | 204,421,016 livres! | Barre supérieure: Toujours visible